Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.680
+0.330 (9.85%)
Oct 24, 2025, 3:44 PM CET
Arctic Bioscience AS Revenue
Arctic Bioscience AS had revenue of 18.70M NOK in the half year ending June 30, 2025, a decrease of -2.02%. This brings the company's revenue in the last twelve months to 45.90M, up 43.97% year-over-year. In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M with 31.55% growth.
Revenue (ttm)
45.90M
Revenue Growth
+43.97%
P/S Ratio
2.15
Revenue / Employee
2.09M
Employees
22
Market Cap
98.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.40M | 10.65M | 31.55% |
| Dec 31, 2023 | 33.76M | -713.30K | -2.07% |
| Dec 31, 2022 | 34.47M | 12.95M | 60.21% |
| Dec 31, 2021 | 21.52M | 922.35K | 4.48% |
| Dec 31, 2020 | 20.59M | -9.45M | -31.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Navamedic ASA | 523.56M |
| Photocure ASA | 522.86M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| ArcticZymes Technologies ASA | 104.33M |